Brief: Endo Aesthetics To Introduce New Clinical Study Of Qwo® (Collagenase Clostridium Histolyticum-Aaes) At The Annual Scale Meeting
05/05/2022 21:42
May 5 (Reuters) - Endo International PLC ENDP.O :
* ENDO AESTHETICS TO INTRODUCE NEW CLINICAL STUDY OF QWO®
(COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES) AT THE ANNUAL SCALE
MEETING
Source text for Eikon: ID:nCNWR0wfFa
Further company coverage: ENDP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes